Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| BELLEVUE GROUP AG | 05-13-2024 | 03-31-2024 | 208 | 6,556,865,621 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC | COM | 1 | $359,783,932 | 8,299,514 | 0.01 | 0.01 | -934,186 | -10.12 | 03-31-2024 |
| ARGENX SE | SPONSORED ADR | 2 | $319,313,220 | 811,016 | 0.00 | 0.01 | -100,514 | -11.03 | 03-31-2024 |
| NEUROCRINE BIOSCIENCES INC | COM | 3 | $283,546,142 | 2,055,874 | 0.00 | 0.00 | -527,676 | -20.42 | 03-31-2024 |
| VERTEX PHARMACEUTICALS INC | COM | 4 | $279,544,188 | 668,750 | 0.00 | 0.01 | -333,985 | -33.31 | 03-31-2024 |
